Impact of COVID-19 on the imaging diagnosis of cardiac disease in Europe.
Michelle Claire WilliamsLeslee ShawCole B HirschfeldPál Maurovich HorvatBjarne L NørgaardGianluca PontoneAmelia Jimenez-HeffernanValentin SinitsynVladimir SergienkoAlexey AnshelesJeroen J BaxRonny BuechelElisa MilanRiemer H J A SlartEdward NicolChiara Bucciarelli-DucciYaroslav PyndaNathan BetterRodrigo CerciSharmila DorbalaPaolo RaggiTodd C VillinesJoao VitolaEli MalkovskiyBenjamin GoebelYosef CohenMichael RandazzoThomas N B PascualMaurizio DondiDiana PaezAndrew J Einsteinnull nullPublished in: Open heart (2021)
The first wave of the COVID-19 pandemic had a significant impact on care of patients with cardiac disease, with substantial regional variations in Europe. This has potential long-term implications for patients and plans are required to enable the diagnosis of non-COVID-19 conditions during the ongoing pandemic.
Keyphrases
- coronavirus disease
- sars cov
- end stage renal disease
- left ventricular
- ejection fraction
- healthcare
- newly diagnosed
- chronic kidney disease
- high resolution
- palliative care
- prognostic factors
- respiratory syndrome coronavirus
- peritoneal dialysis
- health insurance
- patient reported outcomes
- atrial fibrillation
- fluorescence imaging
- affordable care act